异基因造血干细胞移植后供者淋巴细胞输注的优化策略
CHINESE JOURNAL OF INTERNAL MEDICINE（2009）
Abstract
异基因造血干细胞移植(allo-HSCT)是可治愈多种血液系统恶性疾病的有效手段,而移植后疾病的复发一直是限制移植治疗效果的重要原因.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined